Tvardi Therapeutics, Inc. (TVRD) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.26 | +71.5% |
| 2024 | $-11.42 | +56.5% |
| 2023 | $-26.26 | -37.3% |
| 2022 | $-19.12 | -998.9% |
| 2021 | $-1.74 | -1066.7% |
| 2020 | $0.18 | +107.2% |
| 2019 | $-2.49 | -20.9% |
| 2018 | $-2.06 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.26 | +71.5% |
| 2024 | $-11.42 | +56.5% |
| 2023 | $-26.26 | -37.3% |
| 2022 | $-19.12 | -998.9% |
| 2021 | $-1.74 | -1066.7% |
| 2020 | $0.18 | +107.2% |
| 2019 | $-2.49 | -20.9% |
| 2018 | $-2.06 | — |